Vault-13

Artal Group S.A.

LUXEMBOURG, N4 · CIK 1053906 · 13F filing filed 2026-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$931.1m reported value -7.9% vs Q1 2026
2positions
100.0%in top 10
0 new 1 added 1 reduced 0 sold out vs Q1 2026

This report includes the holdings of 5 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CAVA GROUP INC COM CAVA CAVA 6,507,990 $510.7m54.85% 54.85% ReducedShares held: Q3 2025 9.5m, Q4 2025 9.5m, Q1 2026 9.5m, Q2 2026 6.5m -3.0m -3,000,000 -31.6%
2 LEXICON PHARMACEUTICALS INC COM NEW LXRX LXRX 175,156,062 $420.4m45.15% 45.15% AddedShares held: Q3 2025 136.2m, Q4 2025 136.2m, Q1 2026 154.7m, Q2 2026 175.2m +20.4m +20,421,735 13.2%

Trades reported as a company insider since 1 Apr 2026

Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.

DateCompanyTickerTradeShares ValueTheir holding
2026-06-15 CAVA GROUP INC Director CAVA Sold 3,000,000 $270.9m3.0m shares -32%